Remove 2024 Remove Article Remove Hospitals Remove Vaccines
article thumbnail

What Pharmacists Should Know About Medicare Open Enrollment 2024

Digital Pharmacist

The Medicare Open Enrollment period for 2024 is quickly approaching – this is a critical time for both your patients and your pharmacy. Below is a breakdown of what you need to be aware of when assisting patients with 2024 open enrollments, as well as a few tips on how your pharmacy can prepare for this busy time at the pharmacy.

article thumbnail

JCVI backs RSV routine vaccination for babies and older adults in the UK

Hospital Pharmacy Europe

The UK should introduce routine vaccination for respiratory syncytial virus (RSV) to protect babies and older adults, the Joint Committee on Vaccination and Immunisation (JCVI) has recommended. This article was originally published by our sister title Pulse.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Antimicrobial Stewardship in the United kingdom: Perspective From A Pharmacist At A Bone & Joint Hospital

IDStewardship

In this article antimicrobial stewardship in the United Kingdom is discussed. Article posted 1 August 2022. I moved to the southeast and spent my early career working in district general hospitals. I witnessed the devastating impact of orthopaedic infection on patients in the largest orthopaedic hospital in England.

Hospitals 147
article thumbnail

Greater use of diagnostic tests to help tackle antimicrobial resistance is required

Hospital Pharmacy Europe

And we should draw on our experience with Covid-19 to build the ‘toolbox’ for tackling antimicrobial resistance which will include work on diagnostics, surveillance, therapeutics and vaccines, the summary of consultation feedback said. The Government’s National Action Plan goal was to reduce prescribing by 15% by 2024 from a 2014 baseline.

article thumbnail

VPAG rebate calculations risk NHS medicines shortages, warns generics industry

Hospital Pharmacy Europe

The level of annual allowed growth in sales of branded medicines will double from 2% in 2024 to 4% by 2027. Under the agreement, which comes into force in 2024, the pharmaceutical industry will also invest £400m over five years through the Life Sciences Investment Programme.